TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has shared an announcement.
Kintor Pharmaceutical Limited has announced the composition of its board of directors and their respective roles within the company. The board comprises executive, non-executive, and independent non-executive directors, with specific members serving on the audit, remuneration, and nomination committees. This announcement is significant as it outlines the governance structure of the company, which is crucial for stakeholders to understand the leadership and decision-making processes that may impact the company’s strategic direction and operational effectiveness.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on the development and commercialization of innovative therapies, with a particular emphasis on addressing unmet medical needs.
Average Trading Volume: 2,918,958
Technical Sentiment Signal: Buy
Current Market Cap: HK$691.3M
Learn more about 9939 stock on TipRanks’ Stock Analysis page.